Home/Filings/4/0001062993-22-023022
4//SEC Filing

Scaria Abraham 4

Accession 0001062993-22-023022

CIK 0001273636other

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 9:16 AM ET

Size

8.0 KB

Accession

0001062993-22-023022

Insider Transaction Report

Form 4
Period: 2022-11-30
Scaria Abraham
Chief Scientific Officer
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2022-11-30220,0000 total
    Exercise: $1.98Exp: 2031-12-06Common Stock (220,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2022-11-30124,5000 total
    Exercise: $0.40Exp: 2032-08-21Common Stock (124,500 underlying)
Footnotes (1)
  • [F1]At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option.

Issuer

APPLIED GENETIC TECHNOLOGIES CORP

CIK 0001273636

Entity typeother

Related Parties

1
  • filerCIK 0001896175

Filing Metadata

Form type
4
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 9:16 AM ET
Size
8.0 KB